Evolent Health Inc Cl A Com EVH

$4.25 -0.08 (-1.85%)

Valuation

Market cap
489,545,000
Revenue TTM
$1,876,230,000
Net income TTM
$-534,510,000
PE ratio
0.00
Forward PE
—
Profit margin
-28.49%
Debt to equity
2.52

Trading

Volume
1,302,400
Avg volume
2,171,910
Day's range
$4.21 – $4.42
Shares out
113,059,000
Stochastic %K
5%
Beta
1.02
Analysts
Strong Sell
Price target
$5.75

Price

Company profile

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and lead...

Show more

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Industry
Health Information Services
Sector
Healthcare
Phone
571 389 6000
Website
https://www.evolent.com
Address
1812 N. Moore Street, Suite 1705, Arlington, United States

Latest news

Stocktwits

PatBtmn Oct 28, 8:08 PM
$EVH wrong way assholes
0 replies
BRITLS Oct 26, 11:15 PM
$EVH gotta love the low volume big moves
0 replies
BPler Oct 20, 6:51 PM
$EVH Potential catalyst from Trump’s new Executive Order on Women’s Health (Oct 19) 📊 The Quick Take: President Trump established a new NIH division & White House Task Force to accelerate research into complex/chronic conditions affecting women (oncology, autoimmune, etc.). Why it matters for EVH: • Specialty Care Alignment: EVH is a leader in value-based specialty care management. Better data/pathways in high-cost chronic areas directly enhance their clinical software & care models. • Government Contracts: New quality metrics/mandates for Medicaid/Medicare could force payers to optimize women's health outcomes—a core service EVH sells to insurers. • Sentiment: Long-term tailwind. Not an instant revenue spike, but lines up perfectly with their growth vectors. Stock already showing a positive response today. 📈
0 replies
Crom5775 Oct 20, 2:49 PM
$KLRA $EVH healthcare sector strong today. Nice little short squeezes.
0 replies
BPler Oct 19, 7:05 PM
$EVH Positive in the long run or just PR? https://www.reuters.com/legal/litigation/trump-create-new-nih-division-task-force-womens-health-2026-10-19/
0 replies
BPler Oct 16, 7:54 AM
$EVH Even 8 would be still undervalued. I am aiming now at 20s, in hope the upwards trends brings new instutionals and maybe even a buyout/M&A option back on the table
0 replies
StellaLunaSun Oct 15, 5:44 PM
$EVH Congratulations to us all! But it really is fascinating and impressive just how blatantly this share is being manipulated and driven down. Before the last earnings, the share is put on the watch list and the price plummets. Then, after the earnings, it creeps slowly over 3.5 weeks to $5. Then the share price crashes catastrophically, almost back to where it was before the earnings, on the grounds that interest rates are too high and, as the company has so much debt, high interest rates are a nightmare. Now, with no news whatsoever, the share price is soaring in 10 days!!! Back to $5 – why? Because the earnings weren’t rubbish last time either. Suddenly, interest rates don’t matter; suddenly, when the short-sellers let go of the button, the share price takes off. Fundamentally, nothing has changed and interest rates are higher than ever. I’ve never seen the share price rise so quickly. I reckon it’ll keep rising, but I wouldn’t be surprised by a correction but not to 3 back this time.
0 replies
TOMKiLA Oct 15, 1:40 PM
$EVH I want 10$!!!
0 replies